Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
tranexamic acid (cyklokapron) (1 trial)
Hip Fractures (Phase 4)
Trials (1 total)
Trial APIs (1 total)